ArticleToxicology reports2024

Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs.

Ochuko L Erukainure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.